Keywords: provalis, buy, pfizer, drug, 5m, agreed, british
Provalis to buy Pfizer drug for $14.5M
Article | 25 October 2001
Provalis has agreed to buy the British rights to Pfizer's off-patentonce-daily, orally-administered, non-steroidal anti-inflammatory drug, Diclomax (diclofenac), for the treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
